An oral small molecule targeting cancer immunotherapy-induced Cytokine Release Syndrome (CRS) and severe influenza, demonstrating efficacy in reducing inflammation and cytokine levels.

Utilizes artificial intelligence to identify drug targets and treatments for infectious diseases, leveraging data from human challenge trials.